Prismasol BO
Brand Name: Prismasol BO
Generic Name: Hemodialysis and Hemofiltration Solution
Active
Registration Number
DR-XY47808
Dosage Form
Solution for Hemodialysis and Hemofiltration
Issuance Date
March 11, 2022
Expiry Date
March 11, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage StrengthFormulation: Electrolyte Solution in Small Compartment (250 mL) Each L contains: Lactic acid
5.40 g Calcium chloride
5.145 g Magnesium chlroride
2.033 g
Buffer Solution in Large Compartment (4.75 L) Each L contains: Sodium chloride 6.45 g Sodium bicarbonate 3.09 g
Packaging5 Liter-Capacity 2-Compartment (250 mL and 4.75 L) Polyolefin Bag with PA/PP/EVOH Overwrap
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Hemodialysis/Hemofiltration Solution
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Hemodialysis and Hemofiltration SolutionActive
Monograph: hemodialysis and hemofiltration solution